axi-cel in r/r fl: an updated comparison of zuma-5 and the scholar-5 external control cohort
Published 8 months ago • 64 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
2:26
zuma-5: high orr and cr for r/r inhl with axi-cel
-
2:43
long-term follow-up results of zuma-5: axi-cel in patients with r/r indolent nhl
-
3:18
zuma-5: axi-cel for r/r inhl
-
3:46
zuma-5 update: retreatment of r/r inhl with axi-cel
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
1:01:19
june 29, vmr with rabih & cps team - aki
-
26:31
survival analysis overview
-
19:50
the human cell atlas - aviv regev
-
3:21
comparing the efficacy of tisa-cel and axi-cel in patients with r/r fl
-
1:15
primary overall survival analysis of the zuma-7 trial
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:55
updates from zuma-7: axi-cel for r/r dlbcl
-
4:44
zuma-7 subgroup analysis: axi-cel vs soc in elderly patients with r/r lbcl
-
4:03
axi-cel plus rituximab for r/r lbcl and updates from the zuma-14 study
-
1:25
the use of clonoseq to monitor mrd in patients with lbcl treated with axi-cel in zuma-7
-
1:36
real-world comparison of axi-cel and tisa-cel in r/r dlbcl
-
1:20
axi-cel in patients with r/r lbcl in complete metabolic response
-
0:59
matching-adjusted indirect comparison of liso-cel vs axi-cel in the 2l treatment of r/r lbcl
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma